Showing results (81-90 of 197,600) with videos related to
Sort By:
Pageof 19,760
Cancer Cell|December 12, 2003
Oct-3/4 is a dose-dependent oncogenic fate determinantSharon Gidekel, Galina Pizov, Yehudit Bergman, et al.Oncogenesis|October 10, 2018
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypesBatel Shalom, Marganit Farago, Eli Pikarsky, et al.Expert Review of Medical Devices|May 8, 2009
Therapeutic devices for fecal incontinence: dynamic graciloplasty, artificial bowel sphincter and sacral nerve stimulationYair Edden, Steven D WexnerThe Journal of Urology|October 20, 2007
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot studyVladimir Yutkin, Dov Pode, Eli Pikarsky, et al.The American Surgeon|April 1, 1998
Reconstruction of replaced right hepatic artery, to implant a single-catheter port for intra-arterial hepatic chemotherapyA Eid, P Reissman, G Zamir, et al.Molecular and Cellular Biology|February 1, 1995
A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cellsE Ben-Shushan, H Sharir, E Pikarsky, et al.Molecular & Cellular Oncology|June 17, 2016
Animal model studies indicate a candidate biomarker for sorafenib treatment of hepatocellular carcinomaElad Horwitz, Ilan Stein, Yinon Ben-Neriah, et al.The Journal of Pathology|June 7, 2008
A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formationG Vainer, E Vainer-Mosse, A Pikarsky, et al.Langenbeck'S Archives of Surgery|February 22, 2012
Surgical management of Crohn's diseaseVirginia Oliva Shaffer, Steven D WexnerOncology (Williston Park, N.Y.)|September 16, 2000
Clinical status of laparoscopic bowel surgery for GI malignancyS D Wexner, Y H HwangPageof 19,760